600750.SS SHH
China Resources Jiangzhong Pharmaceutical Co.,Ltd
1W: +0.9%
1M: -3.5%
3M: -1.1%
YTD: -10.6%
1Y: +4.7%
3Y: +35.1%
5Y: +162.3%
¥22.53 ($3.36)
+0.23 (+1.03%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$971M
+23.5% ▲
5Y CAGR: +5.2%
Capital Expenditures
$281M
+3.5% ▲
5Y CAGR: +9.0%
Free Cash Flow
$690M
+39.3% ▲
5Y CAGR: +3.9%
Dividends Paid
$778M
-1.2% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
$57M
+484.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $531M | $644M | $708M | $861M | $988M |
| Depreciation & Amort. | $115M | $122M | $126M | $137M | $151M |
| Stock-Based Comp. | $1M | $11M | $9M | $0 | $0 |
| Change in Working Capital | $330M | $312M | $161M | -$140M | -$104M |
| Other Non-Cash Items | -$60M | -$73M | $31M | -$71M | -$63M |
| Operating Cash Flow | $917M | $1.0B | $1.0B | $786M | $971M |
| — Investing Activities — | |||||
| Capital Expenditures | -$188M | -$346M | -$209M | -$291M | -$281M |
| Acquisitions (Net) | $1M | $52K | $0 | $0 | -$49M |
| Investment Purchases | -$5.2B | -$3.3B | -$1.8B | -$995M | -$1.8B |
| Investment Sales | $3.9B | $3.7B | $1.9B | $1.3B | $1.7B |
| Other Investing | $198M | $0 | -$13M | $63M | $98K |
| Investing Cash Flow | -$1.2B | $79M | -$182M | $81M | -$426M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$2M | -$2M | -$2M | $0 |
| Stock Repurchased | -$73M | -$2M | -$1M | -$1M | $0 |
| Dividends Paid | -$309M | -$724M | -$801M | -$768M | -$778M |
| Other Financing | -$41M | $9M | -$13M | -$86M | $291M |
| Financing Cash Flow | -$349M | -$734M | -$817M | -$857M | -$487M |
| Net Change in Cash | -$669M | $362M | $92M | $10M | $57M |
| Cash End of Period | $189M | $550M | $642M | $652M | $709M |
| Free Cash Flow | $729M | $670M | $828M | $495M | $690M |